摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(S)-N,N-diisopropylcarbamic acid 1-phenyl-but-3-enyl ester | 1063723-88-5

中文名称
——
中文别名
——
英文名称
(S)-N,N-diisopropylcarbamic acid 1-phenyl-but-3-enyl ester
英文别名
1-phenylbut-3-enyl diisopropylcarbamate;(-)-(S)-1-phenylbut-3-enyl N,N-diisopropylcarbamate;(S)-1-phenylbut-3-enyl diisopropylcarbamate;[(1S)-1-phenylbut-3-enyl] N,N-di(propan-2-yl)carbamate
(S)-N,N-diisopropylcarbamic acid 1-phenyl-but-3-enyl ester化学式
CAS
1063723-88-5
化学式
C17H25NO2
mdl
——
分子量
275.391
InChiKey
HPQHSMWSUAYUPC-INIZCTEOSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    354.9±32.0 °C(Predicted)
  • 密度:
    0.990±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    4.4
  • 重原子数:
    20
  • 可旋转键数:
    7
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.47
  • 拓扑面积:
    29.5
  • 氢给体数:
    0
  • 氢受体数:
    2

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    (S)-N,N-diisopropylcarbamic acid 1-phenyl-but-3-enyl ester氯磺酸 、 Jones reagent 、 双氧水仲丁基锂sodium acetate 、 cesium fluoride 、 sodium hydroxide 作用下, 以 四氢呋喃乙醚乙醇正己烷二氯甲烷环己烷丙酮 为溶剂, -78.0~20.0 ℃ 、101.33 kPa 条件下, 反应 56.75h, 生成 舍曲林
    参考文献:
    名称:
    Enantioselective Syntheses of (+)-Sertraline and (+)-Indatraline Using Lithiation/Borylation–Protodeboronation Methodology
    摘要:
    The lithiation/borylation-protodeboronation of a homoallyl carbamate was applied to the synthesis of (+)-sertraline and (+)-indatraline. Due to the presence of the alkene, significant modifications of the methodology were required (use of 12-crown-4, TMSCI, H2O), or a solvent switch to CHCI3, to achieve high yields and high selectivities.
    DOI:
    10.1021/ol202251p
  • 作为产物:
    描述:
    1-苯基-3-丁烯-1-醇 在 amino lipase PS 、 sodium hydride 作用下, 以 四氢呋喃 、 mineral oil 为溶剂, 反应 95.25h, 生成 (S)-N,N-diisopropylcarbamic acid 1-phenyl-but-3-enyl ester
    参考文献:
    名称:
    Enantioselective Syntheses of (+)-Sertraline and (+)-Indatraline Using Lithiation/Borylation–Protodeboronation Methodology
    摘要:
    The lithiation/borylation-protodeboronation of a homoallyl carbamate was applied to the synthesis of (+)-sertraline and (+)-indatraline. Due to the presence of the alkene, significant modifications of the methodology were required (use of 12-crown-4, TMSCI, H2O), or a solvent switch to CHCI3, to achieve high yields and high selectivities.
    DOI:
    10.1021/ol202251p
点击查看最新优质反应信息

文献信息

  • Comprehensive Experimental and Theoretical Studies of Configurationally Labile Epimeric Diamine Complexes of α-Lithiated Benzyl Carbamates
    作者:Stefan Grimme、Dieter Hoppe、Heiko Lange、Robert Huenerbein、Birgit Wibbeling、Roland Fröhlich
    DOI:10.1055/s-2008-1067242
    日期:2008.9
    Different primary benzyl-type carbamates were deprotonated by sec-butyllithium in the presence of a tert-leucinol-derived bis(oxazoline) ligand. The resulting configurationally labile epimeric complexes equilibrated and one diastereomer was strongly favored in the equilibria. After dynamic thermodynamic resolution, the complexes could be trapped with different classes of electrophiles to yield highly enantioenriched secondary benzyl carb­amates. The stereochemical course of the substitution reactions was elucidated. High-level quantum chemical investigations were performed and allowed a prediction of both the favored complex and the enantiomeric excess that could be expected within the reactions.
    在叔亮醇衍生的双(恶唑啉)配体存在下,不同主要苄基型氨基甲酸酯被仲丁基锂去质子化。由此得到的构型易变的差向异构复合物达到平衡,其中一个异构体在平衡中占优势。经过动力学热力学拆分后,这些复合物可以通过不同类别的亲电试剂捕获,生成高度对映体富集的次级苄基氨基甲酸酯。取代反应的立体化学过程被阐明。进行了高平的量子化学研究,并能够预测出占优势的复合物和在反应中可预期的对映体过量。
  • Enantioselective synthesis of (<i>R</i>)-tolterodine using lithiation/borylation–protodeboronation methodology
    作者:Stefan Roesner、Varinder K. Aggarwal
    DOI:10.1139/v2012-069
    日期:2012.11

    The synthesis of the pharmaceutical (R)-tolterodine is reported using lithiation/borylation–protodeboronation of a homoallyl carbamate as the key step. This step was tested with two permutations: an electron-neutral aryl Li-carbamate reacting with an electron-rich boronic ester and an electron-rich aryl Li-carbamate reacting with an electron-neutral boronic ester. It was found that the latter arrangement was considerably better than the former. Further improvements were achieved using magnesium bromide in methanol leading to a process that gave high yield and high enantioselectivity in the lithiation/borylation reaction. The key step was used in an efficient synthesis of (R)-tolterodine in a total of eight steps in a 30% overall yield and 90% ee.

    报道了使用化/化-脱硼酸作为关键步骤合成药用(R)-托特罗定的方法。此步骤经过两种排列方式的测试:一个电中性芳基Li-氨基甲酸酯与一个富电子硼酸酯反应,以及一个富电子芳基Li-氨基甲酸酯与一个电中性硼酸酯反应。发现后者的排列比前者要好得多。通过在甲醇中使用溴化镁,进一步改进了方法,导致在化/化反应中获得高产率和高对映选择性的过程。关键步骤在总共八个步骤中以30%的总产率和90%的对映选择性高效合成了(R)-托特罗定
  • Cu(I)-catalyzed stereospecific coupling reactions of enantioenriched α-stannylated benzyl carbamates and their application
    作者:Heiko Lange、Roland Fröhlich、Dieter Hoppe
    DOI:10.1016/j.tet.2008.06.092
    日期:2008.9
    Enantioenriched α-stannylated benzyl carbamates were used in highly stereospecific coupling reactions employing Cu(I) as catalyzing transition metal. Acid chlorides and allyl bromide derivatives were used as electrophilic coupling partners. The reaction was applied in the synthesis of two highly enantioenriched indanoles and one enantioenriched tetraline via intramolecular cyclization reactions.
    富含对映体的α-烷基化苄基氨基甲酸酯被用于高度立体特异性的偶联反应,该反应采用Cu(I)作为催化过渡属。酰和烯丙基生物用作亲电偶联伴侣。该反应通过分子内环化反应用于合成两种高度对映体富集的吲哚和一种对映体富集的四氢
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S,S)-邻甲苯基-DIPAMP (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(-)-4,12-双(二苯基膦基)[2.2]对环芳烷(1,5环辛二烯)铑(I)四氟硼酸盐 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(4-叔丁基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(3-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-4,7-双(3,5-二-叔丁基苯基)膦基-7“-[(吡啶-2-基甲基)氨基]-2,2”,3,3'-四氢1,1'-螺二茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (R)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4S,4''S)-2,2''-亚环戊基双[4,5-二氢-4-(苯甲基)恶唑] (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (3aR,6aS)-5-氧代六氢环戊基[c]吡咯-2(1H)-羧酸酯 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[((1S,2S)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1S,2S,3R,5R)-2-(苄氧基)甲基-6-氧杂双环[3.1.0]己-3-醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (1-(2,6-二氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙蒿油 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫-d6 龙胆紫